Publication | Open Access

Effect of pamidronate 30 mg versus 90 mg on physical function in patients with newly diagnosed multiple myeloma (Nordic Myeloma Study Group): a double-blind, randomised controlled trial

Bone DiseaseHematological MalignancyBone HealthMedicineClinical TrialsMultiple MyelomaOncologyRadiation OncologyPamidronate 30Physical FunctionHealth Sciences